Ambry Genetics has announced that it is now offering Raindance Technologies' RDT 1000 for sequence enrichment and resequencing validation.
This partnership was announced at the recent CHI Next Generation Sequencing Conference in San Diego, California.
'The addition of Raindance's RDT 1000 adds a sequence-enrichment offering while providing an option for customers that are in need of high-throughput targeted sequencing with a high level of coverage, completeness and speed,' said Ardy Arianpour, director of business development at Ambry.
Researchers can utilise the RDT 1000 and Ambry's next-generation services to either reduce study time or to improve study quality by running more samples in the same time within the same experimental budget.
'Ambry is currently offering Raindance's sequence-enrichment solution and may add two new applications, Methyl-Seq and Ultra-Deep Resequencing, in the second half of 2010, further enhancing its customers' abilities to understand the origins and pathways of complex diseases,' said Chris McNary, chief commercial officer of Raindance.
